Snapshot from Jun 25, 2026 at 22:38 UTC. For live data and tracking: View Live
Entities / Companies / DIOSynVax
Entity

DIOSynVax

Tracked across 1 events · 20 articles · First seen Jun 04, 2026 · Last active Jun 08, 2026

Sentiment
70
Attention
6
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
6 70
Tech
AI-Designed Vaccine Enters Human Trials
Researchers at the University of Cambridge, in collaboration with DIOSynVax>>>, have developed the world's first vaccine designed entirely by artificial intelligence to be tested in humans. Led by Professor Jonathan Heeney>>>, this 'super-antigen' vaccine aims…
Impact: DIOSynVax>>> collaborated with the University of Cambridge researchers in developing the new category of vaccine built using artificial intelligence and machine-learning systems.
Jun 04, 2026 · 20 articles
NEWSDESK
Track DIOSynVax live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.